Financial Times Cover Page article, page-51

fully diluted NXR is actually at $20m now. 101m options are all in the money, 41m of them expire end 2015 though.

Makes WBT worth around $65m. If WBT emulates PSY it would triple and NXR would trade around 21 cents. If moving to 51% and WBT = PSY ($180m) then NXR would have a cap of $90m or more than 400% from here.

I am not entirely convinced of the comparison to PSY but I could see WBT trading at $100m if listed on the Nasdaq which would put NXR at 10.5c (at 30%).

They need to really prove this to be superior to iris and show numbers for false non-match rate and false match rate. If they would announce that then that'd be fantastic. I believe that's what they are finalizing now, the final testing phase.